An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium - PubMed (original) (raw)
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium
S A Narod et al. Am J Hum Genet. 1995 Jan.
Abstract
The breast-ovary cancer-family syndrome is a dominant predisposition to cancer of the breast and ovaries which has been mapped to chromosome region 17q12-q21. The majority, but not all, of breast-ovary cancer families show linkage to this susceptibility locus, designated BRCA1. We report here the results of a linkage analysis of 145 families with both breast and ovarian cancer. These families contain either a total of three or more cases of early-onset (before age 60 years) breast cancer or ovarian cancer. All families contained at least one case of ovarian cancer. Overall, an estimated 76% of the 145 families are linked to the BRCA1 locus. None of the 13 families with cases of male breast cancer appear to be linked, but it is estimated that 92% (95% confidence interval 76%-100%) of families with no male breast cancer and with two or more ovarian cancers are linked to BRCA1. These data suggest that the breast-ovarian cancer-family syndrome is genetically heterogeneous. However, the large majority of families with early-onset breast cancer and with two or more cases of ovarian cancer are likely to be due to BRCA1 mutations.
Similar articles
- Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton DF, Ford D, Bishop DT. Easton DF, et al. Am J Hum Genet. 1995 Jan;56(1):265-71. Am J Hum Genet. 1995. PMID: 7825587 Free PMC article. - Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer.
Cornelis RS, Vasen HF, Meijers-Heijboer H, Ford D, van Vliet M, van Tilborg AA, Cleton FJ, Klijn JG, Menko FH, Meera Khan P, et al. Cornelis RS, et al. Hum Genet. 1995 May;95(5):539-44. doi: 10.1007/BF00223866. Hum Genet. 1995. PMID: 7759075 - Linkage analysis of 26 Canadian breast and breast-ovarian cancer families.
Tonin P, Moslehi R, Green R, Rosen B, Cole D, Boyd N, Cutler C, Margolese R, Carter R, McGillivray B, et al. Tonin P, et al. Hum Genet. 1995 May;95(5):545-50. doi: 10.1007/BF00223867. Hum Genet. 1995. PMID: 7759076 - Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers.
Eeles RA. Eeles RA. Breast Cancer Res. 2000;2(4):283-90. doi: 10.1186/bcr70. Epub 2000 May 25. Breast Cancer Res. 2000. PMID: 11250722 Free PMC article. Review. - Breast cancer genetics. Implications of clinical practice.
Olufunmilayo I, Olopade MD, Fackenthal JD. Olufunmilayo I, et al. Hematol Oncol Clin North Am. 2000 Jun;14(3):705-25. doi: 10.1016/s0889-8588(05)70304-x. Hematol Oncol Clin North Am. 2000. PMID: 11203330 Review. No abstract available.
Cited by
- Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer.
Hsu NC, Huang YF, Yokoyama KK, Chu PY, Chen FM, Hou MF. Hsu NC, et al. PLoS One. 2013;8(2):e56256. doi: 10.1371/journal.pone.0056256. Epub 2013 Feb 6. PLoS One. 2013. PMID: 23405268 Free PMC article. - BRCA1: a new candidate gene for bovine mastitis and its association analysis between single nucleotide polymorphisms and milk somatic cell score.
Yuan Z, Chu G, Dan Y, Li J, Zhang L, Gao X, Gao H, Li J, Xu S, Liu Z. Yuan Z, et al. Mol Biol Rep. 2012 Jun;39(6):6625-31. doi: 10.1007/s11033-012-1467-5. Epub 2012 Feb 12. Mol Biol Rep. 2012. PMID: 22327776 - Metastasis of Pregnancy-Associated Breast Cancer (Suspected to Be Hereditary Breast and Ovarian Cancer) to the Brain, Diagnosed at 18 Weeks' Gestation: A Case Report and Review of the Literature.
Okuda T, Yamamoto S, Matsuo S, Kataoka H, Kitawaki J. Okuda T, et al. Case Rep Obstet Gynecol. 2016;2016:9813253. doi: 10.1155/2016/9813253. Epub 2016 Feb 11. Case Rep Obstet Gynecol. 2016. PMID: 26981296 Free PMC article. - Promoter methylation and expression changes of BRCA1 in cancerous tissues of patients with sporadic breast cancer.
Li Q, Wei W, Jiang YI, Yang H, Liu J. Li Q, et al. Oncol Lett. 2015 Apr;9(4):1807-1813. doi: 10.3892/ol.2015.2908. Epub 2015 Jan 27. Oncol Lett. 2015. PMID: 25789047 Free PMC article.
References
- Hum Mol Genet. 1994 Sep;3(9):1679-82 - PubMed
- Am J Hum Genet. 1993 Apr;52(4):792-8 - PubMed
- Am J Hum Genet. 1984 Mar;36(2):460-5 - PubMed
- Nucleic Acids Res. 1990 Aug 11;18(15):4640 - PubMed
- Gynecol Oncol. 1990 Dec;39(3):300-4 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous